Cyproheptadine as an appetite stimulant in children. Is it safe?

Detalhes bibliográficos
Autor(a) principal: Philco Toaza, Priscila Elizabeth
Data de Publicação: 2023
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Sapienza (Curitiba)
Texto Completo: https://journals.sapienzaeditorial.com/index.php/SIJIS/article/view/705
Resumo: Background: Cyproheptadine as an appetite stimulant in children. Is it safe? This drug has been used to increase appetite in pediatric patients, regardless of their sex or the presence of pathological conditions. The effectiveness of this drug in terms of weight gain and growth is still a matter of interest. due to the diversity of conclusions regarding its mechanism of action and therapeutic results. Methods: This bibliographic review of the scientific literature focused on research in order to obtain results around scientific articles related to the use of cyproheptadine as an appetite stimulant in pediatric patients. Results: all the articles analyzed concluded that cyproheptadine is an effective medication for weight gain in pediatric patients, based on appetite stimulation, totally independent of sex and the presence of pathological states. Conclusions: Cyproheptadine is a safe medication, and adequately tolerated in all pediatric patients. It is possible to measure the improvement in weight and growth indices in patients under twelve years of age, if consumption is for at least four consecutive weeks.
id SAPIENZA_1790a88cba1a573bb717edc850b96059
oai_identifier_str oai:ojs2.journals.sapienzaeditorial.com:article/705
network_acronym_str SAPIENZA
network_name_str Sapienza (Curitiba)
repository_id_str
spelling Cyproheptadine as an appetite stimulant in children. Is it safe?cyproheptadine; child development; appetite; weight gainBackground: Cyproheptadine as an appetite stimulant in children. Is it safe? This drug has been used to increase appetite in pediatric patients, regardless of their sex or the presence of pathological conditions. The effectiveness of this drug in terms of weight gain and growth is still a matter of interest. due to the diversity of conclusions regarding its mechanism of action and therapeutic results. Methods: This bibliographic review of the scientific literature focused on research in order to obtain results around scientific articles related to the use of cyproheptadine as an appetite stimulant in pediatric patients. Results: all the articles analyzed concluded that cyproheptadine is an effective medication for weight gain in pediatric patients, based on appetite stimulation, totally independent of sex and the presence of pathological states. Conclusions: Cyproheptadine is a safe medication, and adequately tolerated in all pediatric patients. It is possible to measure the improvement in weight and growth indices in patients under twelve years of age, if consumption is for at least four consecutive weeks.Sapienza Grupo Editorial2023-09-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://journals.sapienzaeditorial.com/index.php/SIJIS/article/view/70510.51798/sijis.v4iSI1.705Sapienza: International Journal of Interdisciplinary Studies; Vol. 4 No. SI1 (2023): Special Issue: Interdisciplinary Studies in Health Sciences; e23044Sapienza: International Journal of Interdisciplinary Studies; Vol. 4 Núm. SI1 (2023): Special Issue: Interdisciplinary Studies in Health Sciences; e23044Sapienza: International Journal of Interdisciplinary Studies; v. 4 n. SI1 (2023): Special Issue: Interdisciplinary Studies in Health Sciences; e230442675-9780reponame:Sapienza (Curitiba)instname:Sapienza Grupo Editorialinstacron:SAPIENZAenghttps://journals.sapienzaeditorial.com/index.php/SIJIS/article/view/705/502Copyright (c) 2023 Priscila Elizabeth Philco Toazahttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessPhilco Toaza, Priscila Elizabeth2023-11-22T16:08:13Zoai:ojs2.journals.sapienzaeditorial.com:article/705Revistahttps://journals.sapienzaeditorial.com/index.php/SIJISPRIhttps://journals.sapienzaeditorial.com/index.php/SIJIS/oaieditor@sapienzaeditorial.com2675-97802675-9780opendoar:2023-11-22T16:08:13Sapienza (Curitiba) - Sapienza Grupo Editorialfalse
dc.title.none.fl_str_mv Cyproheptadine as an appetite stimulant in children. Is it safe?
title Cyproheptadine as an appetite stimulant in children. Is it safe?
spellingShingle Cyproheptadine as an appetite stimulant in children. Is it safe?
Philco Toaza, Priscila Elizabeth
cyproheptadine; child development; appetite; weight gain
title_short Cyproheptadine as an appetite stimulant in children. Is it safe?
title_full Cyproheptadine as an appetite stimulant in children. Is it safe?
title_fullStr Cyproheptadine as an appetite stimulant in children. Is it safe?
title_full_unstemmed Cyproheptadine as an appetite stimulant in children. Is it safe?
title_sort Cyproheptadine as an appetite stimulant in children. Is it safe?
author Philco Toaza, Priscila Elizabeth
author_facet Philco Toaza, Priscila Elizabeth
author_role author
dc.contributor.author.fl_str_mv Philco Toaza, Priscila Elizabeth
dc.subject.por.fl_str_mv cyproheptadine; child development; appetite; weight gain
topic cyproheptadine; child development; appetite; weight gain
description Background: Cyproheptadine as an appetite stimulant in children. Is it safe? This drug has been used to increase appetite in pediatric patients, regardless of their sex or the presence of pathological conditions. The effectiveness of this drug in terms of weight gain and growth is still a matter of interest. due to the diversity of conclusions regarding its mechanism of action and therapeutic results. Methods: This bibliographic review of the scientific literature focused on research in order to obtain results around scientific articles related to the use of cyproheptadine as an appetite stimulant in pediatric patients. Results: all the articles analyzed concluded that cyproheptadine is an effective medication for weight gain in pediatric patients, based on appetite stimulation, totally independent of sex and the presence of pathological states. Conclusions: Cyproheptadine is a safe medication, and adequately tolerated in all pediatric patients. It is possible to measure the improvement in weight and growth indices in patients under twelve years of age, if consumption is for at least four consecutive weeks.
publishDate 2023
dc.date.none.fl_str_mv 2023-09-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://journals.sapienzaeditorial.com/index.php/SIJIS/article/view/705
10.51798/sijis.v4iSI1.705
url https://journals.sapienzaeditorial.com/index.php/SIJIS/article/view/705
identifier_str_mv 10.51798/sijis.v4iSI1.705
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://journals.sapienzaeditorial.com/index.php/SIJIS/article/view/705/502
dc.rights.driver.fl_str_mv Copyright (c) 2023 Priscila Elizabeth Philco Toaza
https://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Priscila Elizabeth Philco Toaza
https://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sapienza Grupo Editorial
publisher.none.fl_str_mv Sapienza Grupo Editorial
dc.source.none.fl_str_mv Sapienza: International Journal of Interdisciplinary Studies; Vol. 4 No. SI1 (2023): Special Issue: Interdisciplinary Studies in Health Sciences; e23044
Sapienza: International Journal of Interdisciplinary Studies; Vol. 4 Núm. SI1 (2023): Special Issue: Interdisciplinary Studies in Health Sciences; e23044
Sapienza: International Journal of Interdisciplinary Studies; v. 4 n. SI1 (2023): Special Issue: Interdisciplinary Studies in Health Sciences; e23044
2675-9780
reponame:Sapienza (Curitiba)
instname:Sapienza Grupo Editorial
instacron:SAPIENZA
instname_str Sapienza Grupo Editorial
instacron_str SAPIENZA
institution SAPIENZA
reponame_str Sapienza (Curitiba)
collection Sapienza (Curitiba)
repository.name.fl_str_mv Sapienza (Curitiba) - Sapienza Grupo Editorial
repository.mail.fl_str_mv editor@sapienzaeditorial.com
_version_ 1797051606497230848